[go: up one dir, main page]

MX2016003950A - Composicion para rocio topica de halobetasol sin propelente. - Google Patents

Composicion para rocio topica de halobetasol sin propelente.

Info

Publication number
MX2016003950A
MX2016003950A MX2016003950A MX2016003950A MX2016003950A MX 2016003950 A MX2016003950 A MX 2016003950A MX 2016003950 A MX2016003950 A MX 2016003950A MX 2016003950 A MX2016003950 A MX 2016003950A MX 2016003950 A MX2016003950 A MX 2016003950A
Authority
MX
Mexico
Prior art keywords
propellant
halobetasol
topical spray
free topical
spray composition
Prior art date
Application number
MX2016003950A
Other languages
English (en)
Inventor
Sumit Madan
Anupam Trehan
Vinod Kumar Arora
Anil Rana
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Publication of MX2016003950A publication Critical patent/MX2016003950A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona a composiciones para rocío tópicas de halobetasol sin propelente que comprenden halobetasol, un emoliente y un solvente no acuoso. También se relaciona a un proceso para la preparación de las composiciones para rocío tópicas sin propelente. Además se relaciona a un método para tratar una condición de la piel tópica al administrar las composiciones para rocío tópicas sin propelente.
MX2016003950A 2013-09-25 2014-09-24 Composicion para rocio topica de halobetasol sin propelente. MX2016003950A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2838DE2013 2013-09-25
PCT/IB2014/064802 WO2015044879A1 (en) 2013-09-25 2014-09-24 Propellant-free topical spray composition of halobetasol

Publications (1)

Publication Number Publication Date
MX2016003950A true MX2016003950A (es) 2016-07-06

Family

ID=51743517

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016003950A MX2016003950A (es) 2013-09-25 2014-09-24 Composicion para rocio topica de halobetasol sin propelente.

Country Status (8)

Country Link
US (1) US20160235766A1 (es)
EP (1) EP3049064A1 (es)
AU (2) AU2014326221A1 (es)
BR (1) BR112016006826A2 (es)
CA (1) CA2925678A1 (es)
MX (1) MX2016003950A (es)
RU (1) RU2016115485A (es)
WO (1) WO2015044879A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170340649A1 (en) 2016-05-30 2017-11-30 Sun Pharmaceutical Industries Limited Topical aqueous spray compositions of halobetasol
US20180028766A1 (en) * 2016-07-27 2018-02-01 Sun Pharmaceutical Industries Limited Touch-free topical spray of halobetasol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5972920A (en) 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
US6579512B2 (en) 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
US20080107758A1 (en) 2001-06-15 2008-05-08 Cuticeuticals, Inc. Topical steroid spray with botanic seed oils
WO2009007785A2 (en) 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
WO2009063493A2 (en) * 2007-09-10 2009-05-22 Glenmark Pharmaceuticals Limited Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
US20100008868A1 (en) * 2007-11-27 2010-01-14 Harry Dugger Sustained remission of atopic dermatitis
DK2473161T3 (en) * 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID

Also Published As

Publication number Publication date
AU2017203916A1 (en) 2017-06-29
WO2015044879A1 (en) 2015-04-02
RU2016115485A (ru) 2017-10-30
AU2014326221A1 (en) 2016-04-28
BR112016006826A2 (pt) 2017-08-01
US20160235766A1 (en) 2016-08-18
EP3049064A1 (en) 2016-08-03
CA2925678A1 (en) 2015-04-02
RU2016115485A3 (es) 2018-06-04

Similar Documents

Publication Publication Date Title
EA201890218A1 (ru) Ретиноидные композиции для местного применения
MX2016003951A (es) Composicion para rocio topica de halobetasol.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
MX381164B (es) Composiciones tópicas de corticosteroides.
PH12015501887B1 (en) Novel bacteriophage and antibacterial composition comprising the same
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
MX370586B (es) Imidazolil enonas triciclicas como moduladores de inflamacion antioxidantes.
EA201690690A1 (ru) Способ придания волосам определённой формы
WO2015077535A3 (en) Novel methods for treating neurodegenerative diseases
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
PH12015501739A1 (en) Topical antifungal composition for treating onychomycosis
HK1212978A1 (zh) 芥子酸的新型衍生物
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
WO2015079469A8 (en) Daphne laureola extracts in the treatment of dermopathies
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
MX2016005645A (es) Composicion farmaceutica topica de acitretina.
EA201591449A1 (ru) Способы получения противораковых композиций
MX2014014816A (es) Composicion farmaceutica para tratar inflamacion y dolor.
EP3068495A4 (en) Retinoid double conjugate compounds, compositions thereof, and methods for treating of skin conditions
PH12016500471A1 (en) Method to treat onychomycosis by hydroxypropyl chitosan
WO2015074969A8 (en) Method of shaping hair
IN2013CH04378A (es)